GL1X · GenesisL1 explorer

MolNFT v1 · #145086 · protein

Structure of vaccine-elicited HIV-1 neutralizing antibody VFP16.02 in complex with HIV-1 fusion peptide residue 512-519

6CDO · VFP16.02 Fab heavy chain: “Structure of vaccine-elicited HIV-1 neutralizing antibody VFP16.02 in complex with HIV-1 fusion peptide…”. X-ray diffraction, 1 ligand (SO4), 4 pockets (best druggability 0.63). MolNFT v1 #145086 on…

PDB
6CDO
Type
protein
Length
457 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
VFP16.02 Fab heavy chain; VFP16.02 Fab light chain; HIV-1 fusion peptide 512-519
Ligands
SO4
Pockets
4 · best druggability 0.63

Structure

x-ray diffraction · 3 distinct chains · 8% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVFP16.02 Fab heavy chainprotein2309% helix, 49% strand—
BVFP16.02 Fab light chainprotein2196% helix, 52% strand—
CHIV-1 fusion peptide 512-519protein80% helix, 0% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 10 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16340.630.7464empty
2520.620.9416empty
3920.480.8125empty
41290.440.7628empty

Interfaces

3 interfaces between chains.

  • A–B · 2316 Ų buried · 21 hydrogen bonds · protein-protein
  • A–C · 359 Ų buried · 8 hydrogen bonds · protein-protein
  • B–C · 241 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 6CDO · Structure of vaccine-elicited HIV-1 neutralizing antibody vFP16.02 in complex with HIV-1… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.